JOEL EICHLER, MD
Ophthalmology Physician · BELLEVILLE, NJ
Individual Active NPI 1326033598
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,059 | 31,733 | $7,708,147 | $3,367,973 | $2,663,484 |
| 2023 | 1,100 | 19,902 | $6,110,972 | $2,618,635 | $2,043,022 |
| 2022 | 1,074 | 9,577 | $5,712,877 | $2,256,483 | $1,754,460 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 19,004 | $34 | $27 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,584 | $332 | $264 |
| 92134 | Imaging of retina | 1,977 | $47 | $37 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,893 | $147 | $117 |
| 67028 | Injection of drug into eye | 1,337 | $150 | $119 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,000 | $109 | $87 |
| 92014 | Established patient complete exam of visual system | 925 | $146 | $110 |
| J2778 | Injection, ranibizumab, 0.1 mg | 642 | $162 | $126 |
| J0178 | Injection, aflibercept, 1 mg | 557 | $831 | $657 |
| 92012 | Established patient problem focused exam of visual system | 373 | $104 | $79 |
| J9035 | Injection, bevacizumab, 10 mg | 257 | $72 | $56 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 231 | $202 | $160 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | MA05418100 | NJ |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | MA05418100 | NJ |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in New Jersey
- NPI 1336646777
- NPI 1841479441
- NPI 1659307858
- NPI 1649266578
- NPI 1043258353
- NPI 1356312508
- NPI 1366482838
- NPI 1891374369
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.